Cervicogenic Headache Dose-Response (CGH D-R)

November 17, 2018 updated by: Mitchell Haas, University of Western States

Dose-Response of Manipulation for Cervicogenic Headache

This study will determine the number of visits to a chiropractor for spinal manipulation and light massage necessary for the optimal relief of cervicogenic headache (headache with associated neck pain). Effectiveness of care will also be determined.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

256

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Minnesota
      • Bloomington, Minnesota, United States, 55431
        • Northwestern Health Sciences University
    • Oregon
      • Portland, Oregon, United States, 97230
        • University of Western States

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • chronic cervicogenic headache
  • threshold pain level
  • threshold headache frequency
  • independently ambulatory
  • English literate
  • candidate for spinal manipulation

Exclusion Criteria:

  • contraindication to thrust spinal manipulation or massage
  • most other headache types
  • Recent manual/exercise therapy from licensed provider for head/neck
  • threshold pain medication use
  • pregnancy
  • involvement with another pain study
  • suspicion of unmanaged depression
  • most cancers
  • hypertension (at least stage II)
  • complicating neurological/spinal conditions
  • pre-randomization noncompliance or cannot/will not comply with protocols
  • health-related litigation, claims, or disability compensation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High dose spinal manipulation
18 visits for spinal manipulation
5 minutes of high velocity, low amplitude thrust to cervical and upper thoracic spine.
Experimental: Moderate dose spinal manipulation
12 visits for spinal manipulation and 6 visits for light massage
5 minutes of high velocity, low amplitude thrust to cervical and upper thoracic spine.
5 minutes of light pressure massage to the neck and upper back
Experimental: Low dose spinal manipulation
6 visits for spinal manipulation and 12 visits for light massage
5 minutes of high velocity, low amplitude thrust to cervical and upper thoracic spine.
5 minutes of light pressure massage to the neck and upper back
Other: High dose massage
18 visits for light massage
5 minutes of light pressure massage to the neck and upper back

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Headache days change from baseline for cervicogenic headache
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Days with cervicogenic headache in the last four weeks from a daily headache diary. Change score = follow-up score - baseline score)
0, 6, 12, 24, 39, 52 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average pain change from baseline for cervicogenic headache
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Average cervicogenic headache pain in the last four weeks evaluated by averaging daily headache diary pain scores. Pain is rated on a 0 to 11 numeric rating scale.
0, 6, 12, 24, 39, 52 weeks
Headache-related disability change from baseline for cervicogenic headaches
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Headache Impact Test (HIT-6)
0, 6, 12, 24, 39, 52 weeks
Headache-related disability days change from baseline
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Number of days in the last four weeks from recall unable to carry out daily work for at least one half day because of cervicogenic headache.
0, 6, 12, 24, 39, 52 weeks
EuroQol-5D change from baseline
Time Frame: 0, 12, 24, 39, 52 weeks
Health-related quality of life
0, 12, 24, 39, 52 weeks
Average pain change from baseline for neck
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Average neck pain in the last four weeks from recall. Pain is rated on a 0 to 11 numeric rating scale.
0, 6, 12, 24, 39, 52 weeks
Neck pain days change from baseline
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Number of days with neck pain in last 4 weeks from recall.
0, 6, 12, 24, 39, 52 weeks
medication use change from baseline
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Number days of use of prescription and nonprescription medications for headaches with neck pain
0, 6, 12, 24, 39, 52 weeks
Outside Care change from baseline
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Visits to providers outside the study for care of cervicogenic headache. Includes hospital and emergency room visits
0, 6, 12, 24, 39, 52 weeks
Patient Satisfaction
Time Frame: week 12
Likert scale for success of care
week 12
Objective biomechanical measures change from baseline
Time Frame: 0, 6 weeks
Measures of cervical joint function and kinematics including global range of motion, spinal segmental joint restriction, pain pressure thresholds
0, 6 weeks
Quality-adjusted life years change from baseline
Time Frame: 0, 12, 24, 39, 52 weeks
utility for cost-effectiveness analysis
0, 12, 24, 39, 52 weeks
Direct & Indirect costs change from baseline
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Health services; lost work days and productivity
0, 6, 12, 24, 39, 52 weeks
Perceived headache average pain change from baseline for cervicogenic headache
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Perceived change in average pain from baseline on a -10 to +10 (21-point) numeric rating scale
0, 6, 12, 24, 39, 52 weeks
Perceived headache improvement from baseline for cervicogenic headache
Time Frame: 0, 6, 12, 24, 39, 52 weeks
Perceived cervicogenic headache improvement from baseline on a 9-point Likert-like scale.
0, 6, 12, 24, 39, 52 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gert Bronfort, DC, PhD, University of Minnesota

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

August 1, 2016

Study Registration Dates

First Submitted

February 2, 2012

First Submitted That Met QC Criteria

February 6, 2012

First Posted (Estimate)

February 9, 2012

Study Record Updates

Last Update Posted (Actual)

November 20, 2018

Last Update Submitted That Met QC Criteria

November 17, 2018

Last Verified

November 1, 2018

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervicogenic Headache

Clinical Trials on Spinal Manipulation

Subscribe